Endosomal NADPH Oxidase Regulates C-Src Activation Following Hypoxia/reoxygenation Injury
Overview
Affiliations
c-Src has been shown to activate NF-kappaB (nuclear factor kappaB) following H/R (hypoxia/reoxygenation) by acting as a redox-dependent IkappaBalpha (inhibitory kappaB) tyrosine kinase. In the present study, we have investigated the redox-dependent mechanism of c-Src activation following H/R injury and found that ROS (reactive oxygen species) generated by endosomal Noxs (NADPH oxidases) are critical for this process. Endocytosis following H/R was required for the activation of endosomal Noxs, c-Src activation, and the ability of c-Src to tyrosine-phosphorylate IkappaBalpha. Quenching intra-endosomal ROS during reoxygenation inhibited c-Src activation without affecting c-Src recruitment from the plasma membrane to endosomes. However, siRNA (small interfering RNA)-mediated knockdown of Rac1 prevented c-Src recruitment into the endosomal compartment following H/R. Given that Rac1 is a known activator of Nox1 and Nox2, we investigated whether these two proteins were required for c-Src activation in Nox-deficient primary fibroblasts. Findings from these studies suggest that both Nox1 and Nox2 participate in the initial redox activation of c-Src following H/R. In summary, our results suggest that Rac1-dependent Noxs play a critical role in activating c-Src following H/R injury. This signalling pathway may be a useful therapeutic target for ischaemia/reperfusion-related diseases.
Zhang H, Lai F, Cheng X, Wang Y Mol Med Rep. 2023; 28(3).
PMID: 37417374 PMC: 10407618. DOI: 10.3892/mmr.2023.13048.
Role of c-Src and reactive oxygen species in cardiovascular diseases.
Hussain M, Ikram W, Ikram U Mol Genet Genomics. 2023; 298(2):315-328.
PMID: 36700976 DOI: 10.1007/s00438-023-01992-9.
NOX as a Therapeutic Target in Liver Disease.
Matuz-Mares D, Vazquez-Meza H, Vilchis-Landeros M Antioxidants (Basel). 2022; 11(10).
PMID: 36290761 PMC: 9598239. DOI: 10.3390/antiox11102038.
The TGF-β/NADPH Oxidases Axis in the Regulation of Liver Cell Biology in Health and Disease.
Herranz-Iturbide M, Penuelas-Haro I, Espinosa-Sotelo R, Bertran E, Fabregat I Cells. 2021; 10(9).
PMID: 34571961 PMC: 8470857. DOI: 10.3390/cells10092312.
Ishii T, Warabi E, Mann G Redox Biol. 2021; 46:102103.
PMID: 34425388 PMC: 8379703. DOI: 10.1016/j.redox.2021.102103.